Physician compensation, 2026

Allergy / Immunology Salary

Allergy and immunology pairs one of the best lifestyles in the subspecialty world with private-practice-friendly economics. Testing and immunotherapy volume, not visit count alone, sets the ceiling.

National median
$305,000
Typical range (p10 to p90)
$255k to $380k
Median annual wRVUs
4,500
Call burden
Low

Median total cash compensation for a mid-career attending. Source: Medscape 2024 (publicly cited). Treat figures as medians, not targets. Real compensation varies widely by geography, employment model, and experience.

Live anonymous cohort, Allergy / Immunology

This cohort is still being built.

We display a live Allergy / Immunology cohort once at least 10 attendings have submitted in the last 24 months. Until then, the published benchmark and regional table below are your reference. Be one of the first to seed it.

Submit your comp anonymously

Allergy / Immunology pay by region

Directional regional medians, anchored to the Medscape 2024 national figure and US Census region adjustments. The South and Midwest pay more in absolute dollars because physician supply is lower and demand is higher; the Northeast runs lower with a higher cost of living.

RegionMedian total compNotes
National median$305,000Doximity 2024 / Medscape 2024 nationwide median.
South$335,500Highest absolute compensation. Houston, Jacksonville, Charlotte, Atlanta lead.
Midwest$329,400Indianapolis and St. Louis often top Doximity median tables.
West$311,100Wide spread. California pays well but is offset by cost of living.
Northeast$295,850Lower in absolute terms (high supply of physicians) and higher cost of living.

Regional figures are modeled adjustments to the national median, not separately surveyed values. Use them for direction, not as an offer benchmark.

What drives Allergy / Immunology compensation

  • Allergy testing and immunotherapy volume, the central revenue and wRVU engine.
  • Private practice ownership, where ancillary economics push income above employed medians.
  • Panel stability and recurring immunotherapy schedules that smooth income.
  • Low call burden, which preserves lifestyle but limits premium upside.

Model your own number, not the median

Allergy / Immunology reports a median of about 4,500 wRVUs a year. Your take-home is that volume times your contract rate, above your threshold. Plug your real visit mix into the calculator and see the bonus your specific offer produces, then negotiate against it.

Negotiation levers at offer time

  • Evaluate testing and immunotherapy volume and how it credits, since it drives the practice economics.
  • If considering private practice, model ancillary revenue against the employed bonus carefully.
  • Value the lifestyle realistically when comparing against higher-burden, higher-ceiling specialties.

Allergy / Immunology at a glance

Median total comp
$305,000
Clinical hours / week
45
Fellowship years
2
Median annual wRVUs
4,500
Private practice share
45%
Call burden
Low

Best lifestyle in IM subspecialty world. Private practice friendly. Typical setting: outpatient clinic, allergy testing/immunotherapy.

Frequently asked questions

What drives allergy and immunology compensation?

Testing and immunotherapy volume. The recurring immunotherapy schedule and in-office testing are the central revenue engine, more so than visit count alone.

Is private practice common in allergy and immunology?

It is one of the more private-practice-friendly subspecialties, and ancillary economics there can push income above employed medians.

Is the lifestyle as good as its reputation?

Call burden is among the lowest in the subspecialty world, which is a major part of the specialty's appeal and a real, if non-cash, component of total value.

Keep going

Educational reference, not financial, billing, or legal advice. Published medians are publicly cited from Medscape 2024. The live cohort is self-reported and anonymized; individual rows are never exposed and a cohort is shown only at a minimum size. Verify any number against your own contract and market before acting on it.